Blood protein may reveal who benefits from depression drug
NCT ID NCT02051413
First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 37 times
Summary
This study looked at whether certain proteins, called beta-arrestins, can help predict how well people with major depression will respond to the antidepressant venlafaxine. Researchers measured these proteins in 67 patients before and during treatment, and compared them to healthy volunteers. The goal was to find a biological marker that could guide more personalized depression treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE EPISODE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Bicetre
Le Kremlin-Bicêtre, 94275, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.